Anthrax Vaccines Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4100984
- 114 Pages
- November 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Anthrax Vaccines market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Anthrax Vaccines market segmented into
Human Use
Cell free PA Vaccines
Based on the end-use, the global Anthrax Vaccines market classified into
Human Use
Animal Use
Based on geography, the global Anthrax Vaccines market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ANTHRAX VACCINES INDUSTRY
2.1 Summary about Anthrax Vaccines Industry
2.2 Anthrax Vaccines Market Trends
2.2.1 Anthrax Vaccines Production & Consumption Trends
2.2.2 Anthrax Vaccines Demand Structure Trends
2.3 Anthrax Vaccines Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Live Vaccines
4.2.2 Cell free PA Vaccines
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Human Use
4.3.2 Animal Use
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Live Vaccines
5.2.2 Cell free PA Vaccines
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Human Use
5.3.2 Animal Use
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Live Vaccines
6.2.2 Cell free PA Vaccines
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Human Use
6.3.2 Animal Use
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Live Vaccines
7.2.2 Cell free PA Vaccines
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Human Use
7.3.2 Animal Use
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Live Vaccines
8.2.2 Cell free PA Vaccines
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Human Use
8.3.2 Animal Use
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Live Vaccines
9.2.2 Cell free PA Vaccines
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Human Use
9.3.2 Animal Use
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Emergent BioSolutions
10.1.2 Merial
10.1.3 Merck
10.1.4 Zoetis
10.1.5 Bayer Sanidad Animal
10.1.6 Colorado Serum
10.1.7 PharmAthene
10.1.8 Tiankang
10.1.9 Biogénesis-Bago
10.1.10 CAVAC
10.1.11 Rosenbusch
10.1.12 Agrovet
10.1.13 Vecol
10.1.14 CVCRI
10.1.15 IVPM
10.1.16 Prondil
10.1.17 CDV
10.1.18 Indian Immunologicals
10.1.19 Botswana Vaccine Institute
10.1.20 Ceva Santé Animale
10.1.21 Intervac
10.1.22 JOVAC
10.2 Anthrax Vaccines Sales Date of Major Players (2017-2020e)
10.2.1 Emergent BioSolutions
10.2.2 Merial
10.2.3 Merck
10.2.4 Zoetis
10.2.5 Bayer Sanidad Animal
10.2.6 Colorado Serum
10.2.7 PharmAthene
10.2.8 Tiankang
10.2.9 Biogénesis-Bago
10.2.10 CAVAC
10.2.11 Rosenbusch
10.2.12 Agrovet
10.2.13 Vecol
10.2.14 CVCRI
10.2.15 IVPM
10.2.16 Prondil
10.2.17 CDV
10.2.18 Indian Immunologicals
10.2.19 Botswana Vaccine Institute
10.2.20 Ceva Santé Animale
10.2.21 Intervac
10.2.22 JOVAC
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Anthrax Vaccines Product Type Overview
2.Table Anthrax Vaccines Product Type Market Share List
3.Table Anthrax Vaccines Product Type of Major Players
4.Table Brief Introduction of Emergent BioSolutions
5.Table Brief Introduction of Merial
6.Table Brief Introduction of Merck
7.Table Brief Introduction of Zoetis
8.Table Brief Introduction of Bayer Sanidad Animal
9.Table Brief Introduction of Colorado Serum
10.Table Brief Introduction of PharmAthene
11.Table Brief Introduction of Tiankang
12.Table Brief Introduction of Biogénesis-Bago
13.Table Brief Introduction of CAVAC
14.Table Brief Introduction of Rosenbusch
15.Table Brief Introduction of Agrovet
16.Table Brief Introduction of Vecol
17.Table Brief Introduction of CVCRI
18.Table Brief Introduction of IVPM
19.Table Brief Introduction of Prondil
20.Table Brief Introduction of CDV
21.Table Brief Introduction of Indian Immunologicals
22.Table Brief Introduction of Botswana Vaccine Institute
23.Table Brief Introduction of Ceva Santé Animale
24.Table Brief Introduction of Intervac
25.Table Brief Introduction of JOVAC
26.Table Products & Services of Emergent BioSolutions
27.Table Products & Services of Merial
28.Table Products & Services of Merck
29.Table Products & Services of Zoetis
30.Table Products & Services of Bayer Sanidad Animal
31.Table Products & Services of Colorado Serum
32.Table Products & Services of PharmAthene
33.Table Products & Services of Tiankang
34.Table Products & Services of Biogénesis-Bago
35.Table Products & Services of CAVAC
36.Table Products & Services of Rosenbusch
37.Table Products & Services of Agrovet
38.Table Products & Services of Vecol
39.Table Products & Services of CVCRI
40.Table Products & Services of IVPM
41.Table Products & Services of Prondil
42.Table Products & Services of CDV
43.Table Products & Services of Indian Immunologicals
44.Table Products & Services of Botswana Vaccine Institute
45.Table Products & Services of Ceva Santé Animale
46.Table Products & Services of Intervac
47.Table Products & Services of JOVAC
48.Table Market Distribution of Major Players
49.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
50.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
51.Table Global Anthrax Vaccines Market Forecast (Million USD) by Region 2021f-2026f
52.Table Global Anthrax Vaccines Market Forecast (Million USD) Share by Region 2021f-2026f
53.Table Global Anthrax Vaccines Market Forecast (Million USD) by Demand 2021f-2026f
54.Table Global Anthrax Vaccines Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
